Prof. Dr. Jianxing He, MD, FACS
Dedicated to clinical work for over 35 years, Dr. He has specialized in clinical, basic, and translational research related to lung cancer surgery. Dr. He has performed more than 10,000 surgeries, including heart-lung transplantation, lung transplantation, and minimally invasive surgery for lung cancer.
Besides his rich clinical experience, Dr. He also has an extensive and impressive array of research experience. He has undertaken or is currently undertaking more than 30 scientific projects supported by the National 863 Program and National Science Foundation. Dr. He has published a total of 572 scientific papers in thoracic surgery, including 239 articles published in Chinese journals and 333 articles published in English journals indexed by SCIE, most of which are the internationally esteemed peer reviewed journals, e.g., NEJM, Lancet, Cell, Lancet Oncology, Nature Medicine, BMJ, JCO, and JAMA INTERN MED. Dr. He has a total impact factor ranking of 2,104.082 combined from his published journals, with a total citation number of his published works reaching 13,691. His H-index was 47.
Calvin S. H. Ng
Research interests: thoracic surgery, lung surgery, chest wall, mediastinum, some basic science
Dr Ng is Professor in Thoracic Surgery at Prince of Wales Hospital, The Chinese University of Hong Kong, and Honorary Consultant Surgeon at New Territory East Cluster (NTEC) hospitals in Hong Kong. He graduated from Imperial College, London in 1999 with BSc (1st Class Honours and 1st in his class), and MBBS (Honours, Distinction in Surgery, Anthony de Rothschild Medal 1st in surgery).
He spent time working for Lord Sir Ara Darzi, Prof. Anthony P.C. Yim in Hong Kong, and as Specialist Registrar and Honorary Research Fellow at the Queen Elizabeth Hospital, University of Birmingham for Mr. Timothy R Graham. He was awarded FRCSEd (CTh) in 2007, and subsequently Doctorate of Medicine in Research (MD(Res)) from University of London for his work on ventilator induced and IR lung injury.
Dr Ng is a pioneer in Single Port (Uniportal) VATS in the Asia-Pacific region, performing the first single port VATS lobectomy in Hong Kong in 2012. His interest in hybrid operating room (HOR) image-guided surgery led to world's first publications of HOR use in single port VATS major lung resection in 2015, and image-guided electromagnetic navigation bronchoscopy (iENB) in 2016. In March 2019, he led his HOR-iENB team to perform Asia-Pacific's first HOR non-invasive transbronchial microwave ablation for lung cancer. He is a Co-PI of NAVABLATE, the international study on bronchoscopic microwave ablation for treatment of lung cancer. Their team subsequently performed the world 1st IllumisiteTM and robotic-assisted bronchoscopy transbronchial microwave ablation. He is also Co-PI of TARGET & POWER studies investigating utilization of robotic assisted bronchoscopy in diagnosis and therapy.
His academic contributions include book chapters in Pearson's Thoracic & Esophageal Surgery 3rd & 4th Eds, Shield's Thoracic Surgery 8th Eds, and more than 260 publications in indexed international journals. Dr Ng is the corresponding Editor of the book Atlas of Uniportal Video Assisted Thoracic Surgery (Springer Science), and Associate Editor of the book Lung Cancer (1st & 2nd Eds).
Dr Ng supervises a research team and postgraduate students to study molecular biology of lung cancer and therapeutic role of ablation for lung diseases. He closely collaborates with Departments of Clinical Oncology (led by Prof Tony Mok), Anatomical Cellular Pathology and Biomechanical Engineering, through several competitive grants to study targeted therapies in lung cancer, magnetic actuated surgical endoscopes, organoids, nanoparticles and aptamers in cancer therapy.